Table 1.
Laboratory data before treatment with pegIFN plus RBV
| WBC | 7,300/µl | ALP | 347 IU/l | HCV genotype | 1b |
| Hb | 16.0 g/dl | γ-GTP | 38 IU/l | RNA load | 5.3 log IU/ml |
| Hct | 47.1% | TP | 8.3 g/dl | ISDR | mixed type (6, 1) |
| Plt | 24.5×104/µl | ALB | 4.3 g/dl | Core 70AA | competitive type |
| PT | 114.0% | TC | 203 mg/dl | Core 91AA | wild type |
| T.Bil | 0.6 mg/dl | UA | 5.7 mg/dl | ||
| D.Bil | 0.1 mg/dl | UN | 13.8 mg/dl | IL-28B rs8099917 | T/T |
| AST | 36 IU/l | Cre | 0.98 mg/dl | HLA DR | B1*01:01/08:03 |
| ALT | 43 IU/l | Glucose | 95 mg/dl | ||
| LDH | 193 IU/l | AFP | 4.9 ng/ml |
WBC = White blood cell count; Hb = hemoglobin; Hct = hematocrit; Plt = platelet; PT = prothrombin time; T.Bil = total bilirubin; D.Bil = direct bilirubin; AST = aspartate aminotransferase; LDH = lactate dehydrogenase; ALP = alkaline phosphatase; γ-GTP = γ-glutamyl transferase; TP = total protein; Alb = albumin; TC = total cholesterol; UA = uric acid; UN = urea nitrogen; Cre = creatinine; AFP = α-fetoprotein; ISDR = interferon sensitivity-determining region; Core 70AA = core 70 amino acid; IL-28B = interleukin-28B; HLA = human leukocyte antigen.